WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

摘要

PHARMACEUTICAL COMPOSITIONS COMPRISING 2-[6-(3-AMINO-PIPERIDIN-1-YL)-3- METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL]-4-FLUORO-BENZONITRILE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ARE PROVIDED AS WELL AS KITS AND ARTICLES OF MANUFACTURE COMPRISING THE PHARMACEUTICAL COMPOSITIONS AS WELL AS METHODS OF USING THE PHARMACEUTICAL COMPOSITIONS.